Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Deficit (Unaudited)

v3.23.1
Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Previously Reported
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock
Previously Reported
Redeemable Convertible Preferred Stock
Retroactive Application of Reverse Capitalization
Common Stock
Common Stock
Previously Reported
Common Stock
Retroactive Application of Reverse Capitalization
Additional Paid-in Capital
Additional Paid-in Capital
Previously Reported
Additional Paid-in Capital
Retroactive Application of Reverse Capitalization
Accumulated Deficit
Accumulated Deficit
Previously Reported
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income (Loss)
Previously Reported
Beginning balance at Dec. 31, 2021 $ (99,357) $ (99,357)       $ 8   $ 8 $ 97,737 $ 97,745 $ (8) $ (197,066) $ (197,066) $ (36) $ (36)
Beginning balance (ASU 2016-13) at Dec. 31, 2021 (122)                     (122)      
Beginning balance, Shares at Dec. 31, 2021           78,601,283 2,849,414 75,751,869              
Beginning balance at Dec. 31, 2021     $ 8,000 $ 8,000                      
Beginning balance, Shares at Dec. 31, 2021     10,947,686 396,870 10,550,816                    
Net loss (71,372)                     (71,372)      
Other comprehensive income, net of tax 47                         47  
Conversion of redeemable convertible preferred stock into common stock 8,000         $ 1     7,999            
Conversion of redeemable convertible preferred stock into common stock, Shares           10,947,686                  
Conversion of redeemable convertible preferred stock into common stock     $ (8,000)                        
Conversion of redeemable convertible preferred stock into common stock, Shares     (10,947,686)                        
Net settlement of liability-classified warrants into common stock 7,616               7,616            
Net settlement of liability-classified warrants into common stock, Shares           694,873                  
Net settlement of equity-classified warrants into common stock           $ 2     (2)            
Net settlement of equity-classified warrants into common stock, Shares           22,343,698                  
Issuance of common stock in connection with the Tailwind Two Merger and PIPE Investment, net of issuance costs 6,928         $ 2     6,926            
Issuance of common stock in connection with the Tailwind Two Merger and PIPE Investment, net of issuance costs, Shares           16,114,695                  
Issuance of common stock in connection with financing transactions, net of issuance costs 40,734         $ 1     40,733            
Issuance of common stock in connection with financing transactions, net of issuance costs, Shares           4,325,000                  
Reclassification of liability-classified warrants and derivatives to equity-classified 11,007               11,007            
Issuance of contingently issuable common stock 44,887               44,887            
Issuance of contingently issuable common stock, Shares           4,095,569                  
Share-based compensation 17,335               17,335            
Exercise of stock options 146               146            
Exercise of stock options, Shares           172,651                  
Ending balance at Mar. 31, 2022 (34,151)         $ 14     234,384     (268,560)   11  
Ending balance, Shares at Mar. 31, 2022           137,295,455                  
Beginning balance at Dec. 31, 2022 (91,421)         $ 14     269,574     (361,168)   159  
Beginning balance, Shares at Dec. 31, 2022           142,503,771                  
Net loss (54,445)                     (54,445)      
Other comprehensive income, net of tax 20                         20  
Share-based compensation 10,166               10,166            
Settlement of vested restricted stock units, net of net share settlements, Shares           1,665,333                  
Exercise of stock options 355               355            
Exercise of stock options, Shares           511,119                  
Ending balance at Mar. 31, 2023 $ (135,325)         $ 14     $ 280,095     $ (415,613)   $ 179  
Ending balance, Shares at Mar. 31, 2023           144,680,223